Cucurbitacin‐B attenuates CCl4‐induced hepatic fibrosis in mice through inhibition of STAT‐3

Volume: 91, Issue: 4, Pages: 933 - 941
Published: Jan 11, 2018
Abstract
Liver fibrosis is a major health concern worldwide. Inhibitors of Signal Transducer and Activator of Transcription 3 ( STAT 3) have been reported to attenuate experimental liver fibrosis. Therefore, the aim of this study was to investigate the potential ameliorative effect of cucurbitacin‐B (Cucu‐B) against CC l 4 ‐induced liver fibrosis in mice. Treatment with Cucu‐B (5 mg/kg) preserved hepatocellular membrane integrity and amended the...
Paper Details
Title
Cucurbitacin‐B attenuates CCl4‐induced hepatic fibrosis in mice through inhibition of STAT‐3
Published Date
Jan 11, 2018
Volume
91
Issue
4
Pages
933 - 941
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.